Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Fasting Serum Levels of Potassium and Sodium in Relation to Long-Term Risk of Cancer in Healthy Men.

Falk RS, Heir T, Robsahm TE, Tretli S, Sandvik L, Erikssen JE, Paulsen JE.

Clin Epidemiol. 2020 Jan 9;12:1-8. doi: 10.2147/CLEP.S216438. eCollection 2020.

2.

Waiting times and treatment following cancer diagnosis: comparison between immigrants and the Norwegian host population.

Thøgersen H, Møller B, Åsli LM, Bhargava S, Kvåle R, Fjellbirkeland L, Robsahm TE, Aaserud S, Babigumira R, Larsen IK.

Acta Oncol. 2020 Jan 10:1-8. doi: 10.1080/0284186X.2019.1711167. [Epub ahead of print]

PMID:
31920119
3.

Association of Lifetime Indoor Tanning and Subsequent Risk of Cutaneous Squamous Cell Carcinoma.

Lergenmuller S, Ghiasvand R, Robsahm TE, Green AC, Lund E, Rueegg CS, Veierød MB.

JAMA Dermatol. 2019 Oct 2:1-9. doi: 10.1001/jamadermatol.2019.2681. [Epub ahead of print]

PMID:
31577329
4.

Serum 25-hydroxyvitamin D levels predict cancer survival: a prospective cohort with measurements prior to and at the time of cancer diagnosis.

Robsahm TE, Tretli S, Torjesen PA, Babigumira R, Schwartz GG.

Clin Epidemiol. 2019 Aug 8;11:695-705. doi: 10.2147/CLEP.S207230. eCollection 2019.

5.

Changes in midlife fitness, body mass index, and smoking influence cancer incidence and mortality: A prospective cohort study in men.

Robsahm TE, Heir T, Sandvik L, Prestgaard E, Tretli S, Erikssen JE, Falk RS.

Cancer Med. 2019 Aug;8(10):4875-4882. doi: 10.1002/cam4.2383. Epub 2019 Jul 4.

6.

Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case-control study.

Berge LAM, Andreassen BK, Stenehjem JS, Larsen IK, Furu K, Juzeniene A, Roscher I, Heir T, Green A, Veierød MB, Robsahm TE.

BMJ Open. 2019 Feb 20;9(2):e025246. doi: 10.1136/bmjopen-2018-025246.

7.

Association of Phenotypic Characteristics and UV Radiation Exposure With Risk of Melanoma on Different Body Sites.

Ghiasvand R, Robsahm TE, Green AC, Rueegg CS, Weiderpass E, Lund E, Veierød MB.

JAMA Dermatol. 2019 Jan 1;155(1):39-49. doi: 10.1001/jamadermatol.2018.3964.

8.

Notice of Retraction and Replacement: Roscher et al. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study. JAMA Dermatol. 2018;154(4):428-434.

Roscher I, Falk RS, Vos L, Clausen OPF, Helsing P, Gjersvik P, Robsahm TE.

JAMA Dermatol. 2018 Dec 1;154(12):1488-1489. doi: 10.1001/jamadermatol.2018.4023. No abstract available.

PMID:
30419111
9.

Bidrar overdiagnostikk til høye melanomtall?

Robsahm TE, Nilsen LTN, Roscher I, Gjersvik P.

Tidsskr Nor Laegeforen. 2018 Aug 20;138(12). doi: 10.4045/tidsskr.18.0547. Print 2018 Aug 21. Norwegian. No abstract available.

PMID:
30132609
Free Article
10.

Quality assurance in melanoma care: The EU-MELACARE study.

Sommariva A, Forsea AM, Agius D, Ascierto PA, Bastiaannet E, Borgognoni L, Demetriou A, Garbe C, Gavric Z, Hocevar M, Innos K, Larønningen S, Louwman M, Robsahm TE, Rutkwoski P, van Akkooi A, Zorzi M, Pasquali S, van de Velde C, Rossi CR.

Eur J Surg Oncol. 2018 Nov;44(11):1773-1778. doi: 10.1016/j.ejso.2018.06.020. Epub 2018 Jul 3.

PMID:
30001892
11.

Differences in cancer survival between immigrants in Norway and the host population.

Thøgersen H, Møller B, Robsahm TE, Babigumira R, Aaserud S, Larsen IK.

Int J Cancer. 2018 Dec 15;143(12):3097-3105. doi: 10.1002/ijc.31729. Epub 2018 Oct 3.

12.

Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts.

McCullough ML, Zoltick ES, Weinstein SJ, Fedirko V, Wang M, Cook NR, Eliassen AH, Zeleniuch-Jacquotte A, Agnoli C, Albanes D, Barnett MJ, Buring JE, Campbell PT, Clendenen TV, Freedman ND, Gapstur SM, Giovannucci EL, Goodman GG, Haiman CA, Ho GYF, Horst RL, Hou T, Huang WY, Jenab M, Jones ME, Joshu CE, Krogh V, Lee IM, Lee JE, Männistö S, Le Marchand L, Mondul AM, Neuhouser ML, Platz EA, Purdue MP, Riboli E, Robsahm TE, Rohan TE, Sasazuki S, Schoemaker MJ, Sieri S, Stampfer MJ, Swerdlow AJ, Thomson CA, Tretli S, Tsugane S, Ursin G, Visvanathan K, White KK, Wu K, Yaun SS, Zhang X, Willett WC, Gail MH, Ziegler RG, Smith-Warner SA.

J Natl Cancer Inst. 2019 Feb 1;111(2):158-169. doi: 10.1093/jnci/djy087.

13.

Why a randomized melanoma screening trial is not a good idea.

Halvorsen JA, Løberg M, Gjersvik P, Roscher I, Veierød MB, Robsahm TE, Nilsen LTN, Kalager M, Bretthauer M.

Br J Dermatol. 2018 Aug;179(2):532-533. doi: 10.1111/bjd.16784. Epub 2018 Jun 12. No abstract available.

PMID:
29893490
14.

Anthropometric factors and Breslow thickness: prospective data on 2570 cases of cutaneous melanoma in the population-based Janus Cohort.

Stenehjem JS, Veierød MB, Nilsen LT, Ghiasvand R, Johnsen B, Grimsrud TK, Babigumira R, Støer NC, Rees JR, Robsahm TE.

Br J Dermatol. 2018 Sep;179(3):632-641. doi: 10.1111/bjd.16825. Epub 2018 Jul 26.

PMID:
29858512
15.

High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry.

Robsahm TE, Helsing P, Nilssen Y, Vos L, Rizvi SMH, Akslen LA, Veierød MB.

Clin Epidemiol. 2018 May 9;10:537-548. doi: 10.2147/CLEP.S151246. eCollection 2018.

16.

Vitamin D, obesity and leptin in relation to bladder cancer incidence and survival: prospective protocol study.

Gislefoss RE, Stenehjem JS, Hektoen HH, Andreassen BK, Langseth H, Axcrona K, Weiderpass E, Mondul A, Robsahm TE.

BMJ Open. 2018 Mar 30;8(3):e019309. doi: 10.1136/bmjopen-2017-019309.

17.

Melanoma staging: Varying precision and terminal digit clustering in Breslow thickness data is evident in a population-based study.

Veierød MB, Page CM, Aaserud S, Bassarova A, Jacobsen KD, Helsing P, Robsahm TE.

J Am Acad Dermatol. 2018 Jul;79(1):118-125.e1. doi: 10.1016/j.jaad.2018.03.023. Epub 2018 Mar 23.

PMID:
29580861
18.

Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.

Roscher I, Falk RS, Vos L, Clausen OPF, Helsing P, Gjersvik P, Robsahm TE.

JAMA Dermatol. 2018 Apr 1;154(4):428-434. doi: 10.1001/jamadermatol.2017.6428.

19.

Trends in incidence of thick, thin and in situ melanoma in Europe.

Sacchetto L, Zanetti R, Comber H, Bouchardy C, Brewster DH, Broganelli P, Chirlaque MD, Coza D, Galceran J, Gavin A, Hackl M, Katalinic A, Larønningen S, Louwman MWJ, Morgan E, Robsahm TE, Sanchez MJ, Tryggvadóttir L, Tumino R, Van Eycken E, Vernon S, Zadnik V, Rosso S.

Eur J Cancer. 2018 Mar;92:108-118. doi: 10.1016/j.ejca.2017.12.024. Epub 2018 Jan 31.

PMID:
29395684
20.

Ultraviolet radiation and skin cancer risk in offshore workers.

Stenehjem JS, Robsahm TE, Bråtveit M, Samuelsen SO, Kirkeleit J, Grimsrud TK.

Occup Med (Lond). 2017 Oct 1;67(7):569-573. doi: 10.1093/occmed/kqx110.

PMID:
29048595
21.

Anthropometric factors and cutaneous melanoma: Prospective data from the population-based Janus Cohort.

Stenehjem JS, Veierød MB, Nilsen LT, Ghiasvand R, Johnsen B, Grimsrud TK, Babigumira R, Rees JR, Robsahm TE.

Int J Cancer. 2018 Feb 15;142(4):681-690. doi: 10.1002/ijc.31086. Epub 2017 Oct 17. Erratum in: Int J Cancer. 2018 Apr 1;142(7):E3.

22.

Prediagnostic serum calcium and albumin and ovarian cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort.

Schwartz GG, Tretli S, Vos L, Robsahm TE.

Cancer Epidemiol. 2017 Aug;49:225-230. doi: 10.1016/j.canep.2017.07.004. Epub 2017 Jul 18.

23.

Aromatic hydrocarbons and risk of skin cancer by anatomical site in 25 000 male offshore petroleum workers.

Stenehjem JS, Robsahm TE, Bråtveit M, Samuelsen SO, Kirkeleit J, Grimsrud TK.

Am J Ind Med. 2017 Aug;60(8):679-688. doi: 10.1002/ajim.22741.

PMID:
28692192
24.

A protocol for prospective studies of 25-hydroxyvitamin D, leptin and body mass index in relation to cutaneous melanoma incidence and survival.

Stenehjem JS, Grimsrud TK, Rees JR, Vos L, Babigumira R, Veierød MB, Robsahm TE.

BMJ Open. 2017 Jun 21;7(6):e014829. doi: 10.1136/bmjopen-2016-014829.

25.

[The 18-year age limit for solarium use should be enforced].

Robsahm TE, Stenehjem JS, Veierød MB.

Tidsskr Nor Laegeforen. 2017 May 2;137(9):608. doi: 10.4045/tidsskr.17.0130. eCollection 2017 May. Norwegian. No abstract available.

26.

Comparison of cancer stage distribution in the immigrant and host populations of Norway, 1990-2014.

Thøgersen H, Møller B, Robsahm TE, Aaserud S, Babigumira R, Larsen IK.

Int J Cancer. 2017 Jul 1;141(1):52-61. doi: 10.1002/ijc.30713. Epub 2017 Apr 8.

27.

Cardiorespiratory fitness and risk of site-specific cancers: a long-term prospective cohort study.

Robsahm TE, Falk RS, Heir T, Sandvik L, Vos L, Erikssen J, Tretli S.

Cancer Med. 2017 Apr;6(4):865-873. doi: 10.1002/cam4.1043. Epub 2017 Mar 20.

28.

Cancer Risk in Women Treated with Fertility Drugs According to Parity Status-A Registry-based Cohort Study.

Reigstad MM, Storeng R, Myklebust TÅ, Oldereid NB, Omland AK, Robsahm TE, Brinton LA, Vangen S, Furu K, Larsen IK.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):953-962. doi: 10.1158/1055-9965.EPI-16-0809. Epub 2017 Jan 20.

29.

Cutaneous head and neck melanoma (CHNM): A population-based study of the prognostic impact of tumor location.

Helsing P, Robsahm TE, Vos L, Rizvi SM, Akslen LA, Veierød MB.

J Am Acad Dermatol. 2016 Nov;75(5):975-982.e2. doi: 10.1016/j.jaad.2016.06.048. Epub 2016 Aug 18.

PMID:
27546291
30.

Cholesterol and prostate cancer risk: a long-term prospective cohort study.

Heir T, Falk RS, Robsahm TE, Sandvik L, Erikssen J, Tretli S.

BMC Cancer. 2016 Aug 17;16:643. doi: 10.1186/s12885-016-2691-5.

31.

Measured cardiorespiratory fitness and self-reported physical activity: associations with cancer risk and death in a long-term prospective cohort study.

Robsahm TE, Falk RS, Heir T, Sandvik L, Vos L, Erikssen JE, Tretli S.

Cancer Med. 2016 Aug;5(8):2136-44. doi: 10.1002/cam4.773. Epub 2016 May 26.

32.

Long Term Association between Serum 25-Hydroxyvitamin D and Mortality in a Cohort of 4379 Men.

Meyer HE, Støer NC, Samuelsen SO, Blomhoff R, Robsahm TE, Brustad M, Giovannucci EL, Bjørge T.

PLoS One. 2016 Mar 17;11(3):e0151441. doi: 10.1371/journal.pone.0151441. eCollection 2016.

33.

Risk of Cancer in Children Conceived by Assisted Reproductive Technology.

Reigstad MM, Larsen IK, Myklebust TÅ, Robsahm TE, Oldereid NB, Brinton LA, Storeng R.

Pediatrics. 2016 Mar;137(3):e20152061. doi: 10.1542/peds.2015-2061. Epub 2016 Feb 4.

34.

The Nordic Health Registries: an important part of modern medical research.

Reigstad MM, Larsen IK, Myklebust TÅ, Robsahm TE, Oldereid NB, Omland AK, Vangen S, Storeng R.

Hum Reprod. 2016 Jan;31(1):216-7. doi: 10.1093/humrep/dev276. Epub 2015 Oct 29. No abstract available.

PMID:
26516204
35.

Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study.

Crocetti E, Mallone S, Robsahm TE, Gavin A, Agius D, Ardanaz E, Lopez MC, Innos K, Minicozzi P, Borgognoni L, Pierannunzio D, Eisemann N; EUROCARE-5 Working Group:.

Eur J Cancer. 2015 Oct;51(15):2179-2190. doi: 10.1016/j.ejca.2015.07.039. Epub 2015 Sep 26.

PMID:
26421821
36.

Cancer risk among parous women following assisted reproductive technology.

Reigstad MM, Larsen IK, Myklebust TÅ, Robsahm TE, Oldereid NB, Omland AK, Vangen S, Brinton LA, Storeng R.

Hum Reprod. 2015 Aug;30(8):1952-63. doi: 10.1093/humrep/dev124. Epub 2015 Jun 24.

37.

Cutaneous squamous cell carcinoma in Norway 1963-2011: increasing incidence and stable mortality.

Robsahm TE, Helsing P, Veierød MB.

Cancer Med. 2015 Mar;4(3):472-80. doi: 10.1002/cam4.404. Epub 2015 Jan 26.

38.

Risk of breast cancer following fertility treatment--a registry based cohort study of parous women in Norway.

Reigstad MM, Larsen IK, Myklebust TÅ, Robsahm TE, Oldereid NB, Omland AK, Vangen S, Brinton LA, Storeng R.

Int J Cancer. 2015 Mar 1;136(5):1140-8. doi: 10.1002/ijc.29069. Epub 2014 Jul 16.

39.

New malignancies after squamous cell carcinoma and melanomas: a population-based study from Norway.

Robsahm TE, Karagas MR, Rees JR, Syse A.

BMC Cancer. 2014 Mar 19;14:210. doi: 10.1186/1471-2407-14-210.

40.

The Inverse Relationship between 25-Hydroxyvitamin D and Cancer Survival: Discussion of Causation.

Robsahm TE, Schwartz GG, Tretli S.

Cancers (Basel). 2013 Nov 5;5(4):1439-55. doi: 10.3390/cancers5041439.

41.

Malignant melanoma--diagnosis, treatment and follow-up in Norway.

Geisler J, Bachmann IM, Nyakas M, Helsing P, Fjøsne HE, Mæhle LO, Aamdal S, Eide NA, Svendsen HL, Straume O, Robsahm TE, Jacobsen KD, Akslen LA.

Tidsskr Nor Laegeforen. 2013 Oct 29;133(20):2154-9. doi: 10.4045/tidsskr.12.1416. Review. English, Norwegian.

42.

Prospective study of Merkel cell polyomavirus and risk of Merkel cell carcinoma.

Faust H, Andersson K, Ekström J, Hortlund M, Robsahm TE, Dillner J.

Int J Cancer. 2014 Feb 15;134(4):844-8. doi: 10.1002/ijc.28419. Epub 2013 Aug 29.

43.

Body mass index, physical activity, and colorectal cancer by anatomical subsites: a systematic review and meta-analysis of cohort studies.

Robsahm TE, Aagnes B, Hjartåker A, Langseth H, Bray FI, Larsen IK.

Eur J Cancer Prev. 2013 Nov;22(6):492-505. doi: 10.1097/CEJ.0b013e328360f434. Review.

PMID:
23591454
44.

Subsite-specific dietary risk factors for colorectal cancer: a review of cohort studies.

Hjartåker A, Aagnes B, Robsahm TE, Langseth H, Bray F, Larsen IK.

J Oncol. 2013;2013:703854. doi: 10.1155/2013/703854. Epub 2013 Mar 12.

45.

Sex differences in rising trends of cutaneous malignant melanoma in Norway, 1954-2008.

Robsahm TE, Bergva G, Hestvik UE, Møller B.

Melanoma Res. 2013 Feb;23(1):70-8. doi: 10.1097/CMR.0b013e32835c7e48.

PMID:
23222548
46.

Vitamin D, season, and risk of prostate cancer: a nested case-control study within Norwegian health studies.

Meyer HE, Robsahm TE, Bjørge T, Brustad M, Blomhoff R.

Am J Clin Nutr. 2013 Jan;97(1):147-54. doi: 10.3945/ajcn.112.039222. Epub 2012 Nov 28.

PMID:
23193007
47.

Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study.

Tretli S, Schwartz GG, Torjesen PA, Robsahm TE.

Cancer Causes Control. 2012 Feb;23(2):363-70. doi: 10.1007/s10552-011-9885-6. Epub 2011 Dec 23.

48.

Incidence trends of melanoma of the skin compared with other localisations, in the Norwegian population, 1956-2005.

Franco-Lie I, Iversen T, Robsahm TE, Abdelnoor M.

Ann Oncol. 2011 Jun;22(6):1443-50. doi: 10.1093/annonc/mdq598. Epub 2010 Dec 6.

49.

[Solaria, vitamin D, and skin cancer].

Veierød MB, Nilsen LT, Robsahm TE.

Tidsskr Nor Laegeforen. 2010 Sep 23;130(18):1818-21. doi: 10.4045/tidsskr.09.0435. Review. Norwegian.

50.

Cancer risk in Norwegian world class athletes.

Robsahm TE, Hestvik UE, Veierød MB, Fagerlie A, Nystad W, Engebretsen L, Tretli S.

Cancer Causes Control. 2010 Oct;21(10):1711-9. doi: 10.1007/s10552-010-9600-z. Epub 2010 Jun 11.

PMID:
20544266

Supplemental Content

Loading ...
Support Center